Elyse Swallow

Manager

Boston

Education

M.P.P. and M.A., economics, Duke University

Summary of Experience

Ms. Swallow specializes in health care consulting, with a specific focus on health economics and outcomes research. She has conducted research on hepatitis C, cancer, and rare genetic diseases. Her work has involved clinical trial data analyses, retrospective claims analyses, patient chart reviews, and economic modeling. Recent projects include evaluating the impact of formulary policies, informing clinical trial design, estimating the comparative safety and efficacy of alternative therapies, analyzing treatment patterns, and assessing the clinical characteristics and economic burden of various illnesses.

Selected Publishing

  • Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012

    Curr Med Res Opin. 2014 Aug;30(8):1537-45
    2014

    Swallow E, Zhang J, Thomason D, Tan RD, Kageleiry A, Signorovitch J

      View abstract
    Health Care
  • Real-world adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertension

    Curr Med Res Opin. 2014 Apr;30(4):637-43
    2014

    Chen S, Macaulay D, Swallow E, Diener M, Farooqui S, Xie J, Wu EQ

      View abstract
    Health Care
  • Comparative Effectiveness of Second-Line Targeted Therapies for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World Observational Studies

    PLoS One. 2014 Dec 10;9(12):e114264
    2014

    Heng DY, Signorovitch J, Swallow E, Li N, Zhong Y, Qin P, Zhuo DY, Wang X, Park J, Stergiopoulos S, Kollmannsberger C

      View abstract
    Health Care
  • Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison

    Exp Hematol Oncol. 2013 Dec 6;2(1):32
    2013

    Signorovitch J, Swallow E, Kantor E, Wang X, Klimovsky J, Haas T, Devine B, Metrakos P 

      View abstract
    Health Care
  • A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care

    Pediatr Pulmonol. 2013 Oct;48(10):954-61
    2012

    Sawicki GS, Ayyagari R, Zhang J, Signorovitch JE, Fan L, Swallow E, Latremouille-Viau D, Wu EQ, Shi L

      View abstract
    Health Care
  • Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes: a matching-adjusted indirect comparison of randomized trials

    Clin Drug Investig. 2011;31(9):665-74. doi: 10.2165/11592490-000000000-00000.
    2011

    Signorovitch J, Wu EQ, Swallow E, Kantor E, Fan L, Gruenberger J

      View abstract
    Health Care
Practices